WO2007139948A3 - Composés d'imidazo-azépinone - Google Patents

Composés d'imidazo-azépinone Download PDF

Info

Publication number
WO2007139948A3
WO2007139948A3 PCT/US2007/012516 US2007012516W WO2007139948A3 WO 2007139948 A3 WO2007139948 A3 WO 2007139948A3 US 2007012516 W US2007012516 W US 2007012516W WO 2007139948 A3 WO2007139948 A3 WO 2007139948A3
Authority
WO
WIPO (PCT)
Prior art keywords
imidazoazepinone
compounds
formula
treatment
methods
Prior art date
Application number
PCT/US2007/012516
Other languages
English (en)
Other versions
WO2007139948A2 (fr
Inventor
Mark Spyvee
Boris M Seletsky
Shawn Schiller
Christina J Shaffer
Jia Liu
Xiang-Yi Li
Qian Chen
Roch Boivin
Original Assignee
Eisai R&D Man Co Ltd
Mark Spyvee
Boris M Seletsky
Shawn Schiller
Christina J Shaffer
Jia Liu
Xiang-Yi Li
Qian Chen
Roch Boivin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd, Mark Spyvee, Boris M Seletsky, Shawn Schiller, Christina J Shaffer, Jia Liu, Xiang-Yi Li, Qian Chen, Roch Boivin filed Critical Eisai R&D Man Co Ltd
Publication of WO2007139948A2 publication Critical patent/WO2007139948A2/fr
Publication of WO2007139948A3 publication Critical patent/WO2007139948A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un composé pur du point de vue énantiomère, de formule I, ainsi que des formulations pharmaceutiques le contenant, et des procédés pour l'utiliser pour le traitement de maladies auto-immunes.
PCT/US2007/012516 2006-05-26 2007-05-25 Composés d'imidazo-azépinone WO2007139948A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US80890606P 2006-05-26 2006-05-26
US80877006P 2006-05-26 2006-05-26
US60/808,906 2006-05-26
US60/808,770 2006-05-26
US81561706P 2006-06-22 2006-06-22
US60/815,617 2006-06-22

Publications (2)

Publication Number Publication Date
WO2007139948A2 WO2007139948A2 (fr) 2007-12-06
WO2007139948A3 true WO2007139948A3 (fr) 2008-01-24

Family

ID=38649936

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/012516 WO2007139948A2 (fr) 2006-05-26 2007-05-25 Composés d'imidazo-azépinone

Country Status (1)

Country Link
WO (1) WO2007139948A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2217242A1 (fr) * 2007-11-15 2010-08-18 Eisai R&D Management Co., Ltd. Procédés d'utilisation
WO2011011494A1 (fr) * 2009-07-21 2011-01-27 Eisai R&D Management Co., Ltd. Composés imidazoazépinones

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0385489A1 (fr) * 1989-03-03 1990-09-05 Eisai Co., Ltd. Composés d'azacyclooctadiènes et leur usage pharmaceutique
EP1619193A1 (fr) * 2003-04-18 2006-01-25 Ono Pharmaceutical Co., Ltd. Compose de spiropiperidine et son utilisation medicinale
WO2006128143A2 (fr) * 2005-05-27 2006-11-30 Eisai Co., Ltd. Composes a base d'hydantoine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0385489A1 (fr) * 1989-03-03 1990-09-05 Eisai Co., Ltd. Composés d'azacyclooctadiènes et leur usage pharmaceutique
EP1619193A1 (fr) * 2003-04-18 2006-01-25 Ono Pharmaceutical Co., Ltd. Compose de spiropiperidine et son utilisation medicinale
WO2006128143A2 (fr) * 2005-05-27 2006-11-30 Eisai Co., Ltd. Composes a base d'hydantoine

Also Published As

Publication number Publication date
WO2007139948A2 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
WO2006086562A3 (fr) Derives de phenylazetidinone
WO2009156462A3 (fr) Composés organiques
HK1166983A1 (zh) 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途
EP1937633B8 (fr) Derives d'acide biphenyloxyacetique utilises pour le traitement de maladies respiratoires
EP1991218A4 (fr) Utilisation de cyclolignans dans le traitement du diabète de type 2 et comme contraceptifs
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
EP1865967A4 (fr) Composes, compositions et methodes de traitement d'infections virales et autres troubles medicaux
IL185277A0 (en) Pharmaceutical compositions containing roflumilast for the treatment of diabetes
WO2008066899A3 (fr) Formulations de nanoparticules et procédés de préparation et d'utilisation de celles-ci
WO2007038459A3 (fr) Composes de carboxyamine et leurs methodes d'utilisation
WO2008030412A3 (fr) Inhibiteurs de la spiropipéridine bêta-sécrétase pour le traitement de la maladie d'alzheimer
WO2008007211A8 (fr) Composés de carboxyamide bicycliques à n-bicycloalkyle substitué
WO2008054698A3 (fr) Composés de spiropipéridine inhibiteurs de la bêta-sécrétase pour le traitement de la maladie d'alzheimer
WO2007070613A3 (fr) Analogues de la rifamycine et leurs utilisations
EP2137175A4 (fr) Nouveau composé à base de phénanthrènequinone et composition pharmaceutique contenant ce dernier utilisé pour le traitement ou la prévention du syndrome métabolique impliquant des maladies
WO2007025146A3 (fr) Preparations de balsalazide, leur procede d'obtention et leurs utilisations
SG158091A1 (en) Imidazoazepinone compounds
WO2009060952A1 (fr) Nouvelle préparation
WO2008146172A3 (fr) Composés présentant une activité antiparasitaire, leurs applications au traitement de maladies infectieuses provoquées par des apicomplexans
WO2007104485A3 (fr) Composés imidazo[2,1-b]thiazole substitués et utilisation dans la fabrication de médicaments
WO2007139833A3 (fr) Composés d'imidazo-azéphinone
ZA200905126B (en) Use of compounds of formula (i) and/or (II) for the preservation of human or animal bodies, and compositions containing the same
WO2006002846A3 (fr) Nouveaux analogues de nitrobenzylthioinosine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07795368

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07795368

Country of ref document: EP

Kind code of ref document: A2